Asian Journal of Transfusion Science
Home About Journal Editorial Board Search Current Issue Ahead of print Back Issues Instructions Subscribe Login  Users: 266 Print this page  Email this page Small font sizeDefault font sizeIncrease font size 


 
CASE REPORT Table of Contents   
Year : 2018  |  Volume : 12  |  Issue : 1  |  Page : 89-92
Detection of antibodies to co-trimoxazole (preservative drug) interfering with routine red cell antibody screening


Department of Transfusion Medicine, Global Health City, Chennai, Tamil Nadu, India

Click here for correspondence address and email

Date of Submission06-Oct-2016
Date of Acceptance14-Aug-2017
Date of Web Publication16-Feb-2018
 

   Abstract 


Drug-dependent antibodies can rarely cause interference in pretransfusion antibody screening. The diluents for commercial reagent red blood cells contain different antibiotics, such as chloramphenicol, neomycin sulfate, and gentamycin as a preservative. The presence of antibodies to a given drug in patient may lead to positive results when performing antibody identification. We present a rare case of detection of anti-co-trimoxazole antibody during routine antibody screening in a female patient undergoing neurosurgery. These antibodies mimicked as antibody against high-frequency red cell antigens reacting in both saline phase as well as antiglobulin phase. Anti-co-trimoxazole antibody was confirmed by repeating antibody screen using reagent red cells of different manufacturers with and without co-trimoxazole drug as preservative as well as using washed red cell panels. There were no associated clinical or laboratory evidence of hemolysis.

Keywords: Antibody identification, drug-induced antibodies, high-frequency antigen, preservative, red cell reagents

How to cite this article:
Sachan D, Kumar S A. Detection of antibodies to co-trimoxazole (preservative drug) interfering with routine red cell antibody screening. Asian J Transfus Sci 2018;12:89-92

How to cite this URL:
Sachan D, Kumar S A. Detection of antibodies to co-trimoxazole (preservative drug) interfering with routine red cell antibody screening. Asian J Transfus Sci [serial online] 2018 [cited 2018 Dec 17];12:89-92. Available from: http://www.ajts.org/text.asp?2018/12/1/89/225676





   Introduction Top


In immunohematology, we often encounter reactions which are not due to blood group antibodies while typing red cells, compatibility testing, or antibody screening. If a patient has an antibody that reacts with a chemical present in the commercial red blood cell (RBC) suspension, anti-sera, or potentiators (low ionic strength solution), it can lead to serious errors or incompatible crossmatches or delay in supplying blood for transfusion.

Antibodies are reported against various chemicals added to the reagents, for example, antibiotics, antifungal, sugars, and dyes.[1] Various manufacturers add antibiotics to the red cell suspension media. Antibodies to chloramphenicol,[2] neomycin sulfate,[3] gentamicin,[4] etc., have been reported. We present here a rare case of anti-co-trimoxazole drug-induced antibody detected during routine antibody screening.


   Case Report Top


A 36-year-old female admitted with complaints of generalized weakness and headache for 3 days for revision of ventriculoperitoneal shunt surgery. She was a known case of hydrocephalus, aseptic meningitis, and was on regular antiepileptic, antidepressant and antiosteoporotic medications.

On admission, her hemoglobin was 11.5 g% and a type and screen request was received by the blood bank. Blood group was confirmed as A Rh (D) positive. Her serum was screened for irregular antibodies using commercial three-cell antibody screening panel (ID Diacell I-II-III, Diamed Cressiur sur Morat, Switzerland) and showed a pan-reactive 4+ reaction in AHG phase with negative autocontrol. Antibody identification using ID-Diapanel (Diamed Cressiur sur Morat, Switzerland) showed 4+ pan-reactive reaction with all 11 panel cells with negative autocontrol giving suspicion of antibody against High Frequency antigen (HFA) [Figure 1]. The direct antiglobulin test using anti-IgG and anti-C3d were negative. The neurosurgery team was explained about the positive antibody screen and possibility of antibody against HFA.
Figure 1: Antibody identification showing pan-reactive results using ID-Diapanel

Click here to view


To further characterize the nature of antibody against HFA and to rule out anti-IH antibody with wide thermal amplitude, patient serum was further tested for cold antibody screen using ID-DiaCell I-II-III (Diamed Cressier sur Morat, Switzerland) in saline phase which showed pan-reactive 4+.

On crossmatching with group specific (A RhD positive) packed red cells using LISS/Coombs gel card and were found to be compatible raising suspicion against Anti-HFA. The crossmatches and indirect Coombs tests (ICT) were repeated with tube method which showed negative results giving a first suspicion for anti-preservative red cell antibody.

The patient sample was also tested with commercial screen cells of different manufacturers (Surgiscreen cells using Glass bead method, Ortho Clinical Diagnostics; Matrix Erygen AS reagent red cells; Tulip diagnostics). The ICT results with other commercial red cells were nonreactive. The antibody preservative in commercial reagent red cells and antibody screen results with patient serum are shown in [Table 1]. The preservative present in ID-Diacell I-II-III (Bio-Rad Laboratories) is the antibiotics trimethoprim (TMP) and sulfamethoxazole which were absent in surgiscreen reagent red cells (Ortho Clinical Diagnostics) and Matrix Erygen AS reagent red cells (Tulip diagnostics).
Table 1: Patient red cell antibody screen results with commercial red cell reagents

Click here to view


To confirm the nature of drug (anti-preservative)-induced antibodies, reagent red cells were washed thrice with saline and ICT was repeated which came negative with washed reagent red cells [Figure 2]. However, after prolonged incubation of washed reagent cells in ID-Diluent 2 (LISS solution) as well as BLISS solution (Ortho Clinical Diagnostics), ICT was showing weak reactive (1+). Furthermore, on incubating the in-house donor red cells with BLISS solution for 30 min in room temperature, the crossmatch with patient serum showed 1+ reactive. On reviewing the manufacture inserts, ID–Diluent 2 as well as Ortho BLISS solution for red cell suspensions had preservatives, the antibiotics TMP and sulfamethoxazole (SMX).
Figure 2: Antibody screen using (a) saline washed ID-Diacell panel cells and (b) unwashed panel cells

Click here to view


There was no history of recent intake of drug though the history of intake of drug could not be asserted. It was confirmed to be an anti-co-trimoxazole drug-induced antibody against preservative media in reagent red cells. There were no clinical features of hemolysis. Blood transfusion was not required during surgery. The patient and the physician were explained regarding potential risk of hemolysis if the same drug is taken. The possibility of co-trimoxazole drug-induced aseptic meningitis also could not be ruled out. The patient was discharged with stable status with proper advice.


   Discussion Top


During immunohematological workup, whenever an ABO discrepancy is encountered or when a patient's serum reacts with all RBC's, often presence of an antibody to a blood group antigen is assumed. This case highlights that these reactions can be unrelated to blood group antigens.

In blood banks, we routinely use commercial anti-sera, commercial RBC suspending media, commercial antibody potentiators, and commercial RBC panels. These reagents often have preservative or antibiotics such as chloramphenicol, neomycin sulfate, and gentamycin. The presence of antibodies to a given drug may lead to a positive result when performing antibody identification.

The presence of antibodies against a preservative drug can be assessed only when patient's serum containing antibody is added to RBCs in the presence of antibiotic (i.e., the commercial RBC suspension media). We demonstrated that serum containing antibodies against co-trimoxazole gave positive reactions with commercial panel cells with the preservative as co-trimoxazole but negative reaction with other commercial RBC panels without the same drug as well as with native or washed red cells.

Co-trimoxazole is an antibacterial drug, a combination of two drugs: TMP and SMX. These antibodies against preservative should be suspected and given attention whenever conflicting results are noted in antibody screening with different techniques of similar sensitivities, pan-reactive results, and absence of clinical and biochemical data matching with results. These in vitro reactions due to preservative antibiotic drugs are similar to reactions of antibodies causing drug-induced immune hemolytic anemia which follow “immune complex mechanism.”

Antibiotics TMP and sulfamethoxazole was present in ID-DiaCell I-II-III (Bio-Rad Laboratories) reagent red cells as well as LISS and BLISS solution. However, the variation of concentration of these antibiotics (not mentioned in manufacturing inserts) may have caused the difference in reaction while repeating ICT using reagent red cells without co-trimoxazole (Ortho Clinical Diagnostics). Reagent red cells (Biorad) which were already suspended in drug were causing high grade of reaction (4+) which were turning negative after saline wash whereas LISS and BLISS solution required prolonged (more than 30 min) incubation of reagent red cells with these diluents before adding serum to get low-grade (1+) positivity which explains negative results with Surgiscreen red cells during antibody screen.

In Pham et al.,[5] where 3 cases were reported against subjects produced antibodies against co-trimoxazole in three different patterns: Antibodies to both co-trimoxazole components (antibodies against TMP and SMX) or against one component only. In his study, anti-TMP antibodies gave negative reaction with Ko RBCs, showing anti-Ku specificity in 2 cases and anti – SMX antibody with anti-H specificity in one case. LISS solution without co-trimoxazole could not be used as suggested by Pham et al.[5]

Our case report shows that antibodies against co-trimoxazole can present as antibodies against a high-prevalence antigen which was in accordance to other studies.[6],[7] Further specificity analysis could not be done in our case due to unavailability of panel of RBCs lacking a high prevalence antigen. Different pattern of antibody reactivity is reported by Arndt's et al. and suggests that the immune response by a given drug may vary in patients exposed to drug and is governed by many factors.[8] The drug-induced antibodies may recognize different RBC components and differ in blood group specificity; therefore, it is important to know the formula of media used in reagents and laboratories to interpret the data correctly. These anti-preservative antibodies should be assessed carefully, and despite the absence of clinical events, the avoidance of drug should be recommended.

The clinical importance of antibodies against co-trimoxazole is not yet clear. These antibodies have shown to be associated with hemolytic anemia, renal failure, aseptic meningitis. Although we did not find any clinical or biochemical signs of hemolysis in the patient, we advised to avoid the use of co-trimoxazole as these antibodies have been associated with drug-induced immune hemolytic anemia and renal failure.[9]

Finally, these antibodies might be a serological finding only. Further investigations and follow-up required for confirmation of drug-dependent antibodies and associated hemolytic anemia and nature of these antibodies.

Acknowledgment

We thank Dr. Dhinesh Kumar, HOD, Department of Transfusion Medicine, Billroth Hospital and Dr. K. Cheirmaraj, Technical support, Ortho Clinical Diagnostics for their help in the study.

Declaration of patient consent

The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.



 
   References Top

1.
Garratty G.In vitro reactions with red blood cells that are not due to blood group antibodies: A review. Immunohematology 1998;14:1-11.  Back to cited text no. 1
[PUBMED]    
2.
Hysell JK, Gray JM, Hysell JW, Beck ML. An anti-neomycin antibody interfering with ABO grouping and antibody screening. Transfusion 1975;15:16-22.  Back to cited text no. 2
[PUBMED]    
3.
Beattie KM, Ferguson SJ, Burnie KL, Barr RM, Urbaniak ST, Atherton PJ. Chloramphenicol antibody causing interference in antibody detection and identification tests. Transfusion 1976;16:174-7.  Back to cited text no. 3
[PUBMED]    
4.
Peloquin PM, Hawkes D, Mayers S. An IgG, gentamicin sulfate-dependent antibody found during prenatal antibody screening. Vox Sang 1986;51:321-3.  Back to cited text no. 4
[PUBMED]    
5.
Pham BN, Gien D, Bensaad F, Babinet J, Dubeaux I, Rouger P, et al. Antibodies to co-trimoxazole (trimethoprim and/or sulfamethoxazole) related to the presence of the drug in a commercial low-ionic-strength solution. Transfusion 2012;52:844-8.  Back to cited text no. 5
[PUBMED]    
6.
Petz LD, Garratty G. Immune Haemolytic Anemias. 2nd ed. Philadelphia, PA: Churchill Livingstone; 2004.  Back to cited text no. 6
    
7.
Salama A, Mueller-Eckhardt C. On the mechanisms of sensitization and attachment of antibodies to RBC in drug-induced immune hemolytic anemia. Blood 1987;69:1006-10.  Back to cited text no. 7
[PUBMED]    
8.
Arndt PA, Garratty G, Wolf CF, Rivera M. Haemolytic anaemia and renal failure associated with antibodies to trimethoprim and sulfamethoxazole. Transfus Med 2011;21:194-8.  Back to cited text no. 8
[PUBMED]    
9.
Ermis B, Caner I, Karacan M, Olgun H. Haemolytic anaemia secondary to trimethoprim/sulfamethoxazole use. Thromb Haemost 2003;90:158-9.  Back to cited text no. 9
[PUBMED]    

Top
Correspondence Address:
Deepti Sachan
Department of Transfusion Medicine, Global Health City, #439, Cheran Nagar, Perumbakkam, Chennai, Tamil Nadu
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ajts.AJTS_119_16

Rights and Permissions


    Figures

  [Figure 1], [Figure 2]
 
 
    Tables

  [Table 1]



 

Top
 
  Search

  
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Email Alert *
    Add to My List *
* Registration required (free)  


    Abstract
   Introduction
   Case Report
   Discussion
    References
    Article Figures
    Article Tables

 Article Access Statistics
    Viewed660    
    Printed23    
    Emailed0    
    PDF Downloaded7    
    Comments [Add]    

Recommend this journal

Association Contact us | Sitemap | Advertise | What's New | Feedback | Copyright and Disclaimer

2006 - Asian Journal of Transfusion Science | Published by Wolters Kluwer - Medknow
Online since 10th November, 2006